{"name":"Humanis Saglık Anonim Sirketi","slug":"humanis-sagl-k-anonim-sirketi","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":8,"colorKey":"oncology","drugs":[{"name":"Bosentan Dispersible Tablets","genericName":"Bosentan Dispersible Tablets","slug":"bosentan-dispersible-tablets","indication":"Other","status":"phase_1"},{"name":"Macitentan and Tadalafil","genericName":"Macitentan and Tadalafil","slug":"macitentan-and-tadalafil","indication":"Chronic treatment of PAH","status":"marketed"},{"name":"Nilemdo® Film-coated tablets","genericName":"Nilemdo® Film-coated tablets","slug":"nilemdo-film-coated-tablets","indication":"Other","status":"phase_1"},{"name":"Sacubitril and Valsartan-Test product","genericName":"Sacubitril and Valsartan-Test product","slug":"sacubitril-and-valsartan-test-product","indication":"Other","status":"phase_1"},{"name":"Segluromet film coated tablets","genericName":"Segluromet film coated tablets","slug":"segluromet-film-coated-tablets","indication":"Other","status":"phase_1"},{"name":"Selexipag Film Coated Tablets","genericName":"Selexipag Film Coated Tablets","slug":"selexipag-film-coated-tablets","indication":"Other","status":"phase_1"},{"name":"Tracleer Tablet for Oral Suspension","genericName":"Tracleer Tablet for Oral Suspension","slug":"tracleer-tablet-for-oral-suspension","indication":"Other","status":"phase_1"},{"name":"Vonoprazan Tablets","genericName":"Vonoprazan Tablets","slug":"vonoprazan-tablets","indication":"Gastroesophageal reflux disease (GERD)","status":"marketed"}]}],"pipeline":[{"name":"Bosentan Dispersible Tablets","genericName":"Bosentan Dispersible Tablets","slug":"bosentan-dispersible-tablets","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Macitentan and Tadalafil","genericName":"Macitentan and Tadalafil","slug":"macitentan-and-tadalafil","phase":"marketed","mechanism":"Small molecule","indications":["Chronic treatment of PAH"],"catalyst":""},{"name":"Nilemdo® Film-coated tablets","genericName":"Nilemdo® Film-coated tablets","slug":"nilemdo-film-coated-tablets","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Sacubitril and Valsartan-Test product","genericName":"Sacubitril and Valsartan-Test product","slug":"sacubitril-and-valsartan-test-product","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Segluromet film coated tablets","genericName":"Segluromet film coated tablets","slug":"segluromet-film-coated-tablets","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Selexipag Film Coated Tablets","genericName":"Selexipag Film Coated Tablets","slug":"selexipag-film-coated-tablets","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Tracleer Tablet for Oral Suspension","genericName":"Tracleer Tablet for Oral Suspension","slug":"tracleer-tablet-for-oral-suspension","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Vonoprazan Tablets","genericName":"Vonoprazan Tablets","slug":"vonoprazan-tablets","phase":"marketed","mechanism":"Vonoprazan is a potassium-competitive acid blocker that reversibly inhibits the H+/K+-ATPase pump in gastric parietal cells to reduce gastric acid secretion.","indications":["Gastroesophageal reflux disease (GERD)","Peptic ulcer disease","Helicobacter pylori eradication (as part of combination therapy)"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":8,"phaseCounts":{"phase_1":6,"marketed":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}